Need professional-grade analysis? Visit stockanalysis.com
$11.01B
N/A
N/A
N/A
Price Chart
Risk-Adjusted Performance
Huapont Life Sciences Co Ltd (002004) Price Performance
Huapont Life Sciences Co Ltd (002004) trades on SHE in CNY. The company is classified in the Basic Materials sector under the Agricultural Inputs industry. The stock currently trades at CNY4.90, down 4.11% from the previous close.
Over the past year, 002004 has traded between a low of CNY3.63 and a high of CNY5.88. The stock has gained 26.1% over this period. It is currently 16.7% below its 52-week high.
Huapont Life Sciences Co Ltd has a market capitalization of $11.01B.
About Huapont Life Sciences Co Ltd
Huapont Life Sciences Co.,Ltd. engages in the medicine, medical care, agrochemicals, new materials, tourism, and other businesses in China and internationally. The company is involved in the production and sale of pharmaceutical preparations and raw materials. It also offers medicines for skin, tuberculosis, anti-infection, respiratory, anti-tumor, and cardiovascular, as well as health management products. In addition, the company provides pesticide technical, intermediate and preparation products, and GLP registration technical services. Further, it engages in the research and development, production, and sales of fine chemical products and polymer materials, as well as provides tourism services and agent for the promotion of preparation products. The company was formerly known as Huapont-Nutrichem Co., Ltd. and changed its name to Huapont Life Sciences Co.,Ltd. in September 2015. Huapont Life Sciences Co.,Ltd. was founded in 1992 and is headquartered in Chongqing, China.
Company Info
- Sector
- Basic Materials
- Industry
- Agricultural Inputs
- Exchange
- SHE
- Currency
- CNY
- Country
- China
Financial Metrics
- Revenue (TTM)
- N/A
- EBITDA
- N/A
- Profit Margin
- N/A
- EPS (TTM)
- N/A
- Book Value
- N/A
Technical Indicators
- 52 Week High
- CN¥6.08
- 52 Week Low
- CN¥3.59
- 50 Day MA
- CN¥5.33
- 200 Day MA
- CN¥4.71
- Beta
- N/A
Valuation
- Trailing P/E
- N/A
- Forward P/E
- N/A
- Price/Sales
- N/A
- Price/Book
- N/A
- Enterprise Value
- $11.01B